BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7012667)

  • 21. Alteration of the neuronal response to amphetamine in the neostriatum by pretreatment with a centrally acting anticholinergic.
    Wilson CJ; Juraska JM; Groves PM
    Neuropharmacology; 1977; 16(7-8):455-61. PubMed ID: 917251
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution to the study of nigrostriatal dopaminergic neuron activity using electrochemical detection of dopamine release in the striatum of freely moving animals.
    Nieoullon A; Forni C; el Ganouni S
    Ann N Y Acad Sci; 1986; 473():126-40. PubMed ID: 3099623
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of anesthetics and electrical stimulation on nigrostriatal dopaminergic neurons.
    McCown TJ; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1983 Mar; 224(3):489-93. PubMed ID: 6827473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine.
    White NM
    Life Sci; 1988; 43(1):7-12. PubMed ID: 3133532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
    Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
    Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
    [No Abstract]   [Full Text] [Related]  

  • 26. Responses of striatal neurons in the behaving monkey. 1. Head of the caudate nucleus.
    Rolls ET; Thorpe SJ; Maddison SP
    Behav Brain Res; 1983 Feb; 7(2):179-210. PubMed ID: 6830651
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulatory impairments following selective 6-OHDA lesions of the neostriatum.
    Dunnett SB; Iversen SD
    Behav Brain Res; 1982 Feb; 4(2):195-202. PubMed ID: 7059376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of nigral dopaminergic neurons after lesion of the neostriatum in rats.
    Doudet D; Gross C; Seal J; Bioulac B
    Brain Res; 1984 Jun; 302(1):45-55. PubMed ID: 6733505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unitary activity of the substantia nigra following stimulation of the striatum in the awake monkey.
    Feger J; Ohye C
    Brain Res; 1975 May; 89(1):155-9. PubMed ID: 807295
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity.
    Bunney BS; Skirboll LR; Grace AA
    Adv Biochem Psychopharmacol; 1980; 24():267-73. PubMed ID: 7405666
    [No Abstract]   [Full Text] [Related]  

  • 31. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation?
    Samuel D; Kumar U; Nieoullon A
    J Neurochem; 1988 Dec; 51(6):1704-10. PubMed ID: 3141584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral implications of dopaminergic neurons in the mesolimbic system.
    Iversen SD; Koob GF
    Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
    [No Abstract]   [Full Text] [Related]  

  • 33. Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways.
    Chéramy A; Leviel V; Daudet F; Guibert B; Chesselet MF; Glowinski J
    Neuroscience; 1981; 6(12):2657-68. PubMed ID: 7322356
    [No Abstract]   [Full Text] [Related]  

  • 34. Spontaneous activity of type II but not type I striatal neurons is correlated with recovery of behavioral function after dopamine-depleting brain lesions.
    Nisenbaum ES; Stricker EM; Zigmond MJ; Berger TW
    Brain Res; 1988 Nov; 473(2):389-93. PubMed ID: 3148358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions.
    Garris PA; Ciolkowski EL; Wightman RM
    Neuroscience; 1994 Mar; 59(2):417-27. PubMed ID: 8008199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional and ultrastructural localization of tyrosine hydroxylass by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems.
    Pickel VM; Joh TH; Reis DJ
    Adv Biochem Psychopharmacol; 1977; 16():321-9. PubMed ID: 18885
    [No Abstract]   [Full Text] [Related]  

  • 37. The response of striatal cells upon stimulation of the dorsal and median raphe nuclei.
    Olpe HR; Koella WP
    Brain Res; 1977 Feb; 122(2):357-60. PubMed ID: 837235
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection.
    Fallon JH; Wang C; Kim Y; Canepa N; Loughlin S; Seroogy K
    Neurosci Lett; 1983 Oct; 40(3):233-8. PubMed ID: 6316210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.